SPY322.86+0.22 0.07%
DIA267.39-0.19 -0.07%
IXIC10,665.98+33.00 0.31%

Raymond James Maintains Outperform on Haemonetics, Raises Price Target to $100

Raymond James maintains Haemonetics (NYSE:HAE) with a Outperform and raises the price target from $93 to $100.

· 09/08/2020 07:27
Raymond James maintains Haemonetics (NYSE:HAE) with a Outperform and raises the price target from $93 to $100.